HB Wealth Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Buy
14,843
+107
+0.7% +$14K 0.01% 520
2025
Q4
$1.79M Buy
14,736
+258
+2% +$32.4K 0.01% 429
2025
Q3
$1.62M Buy
14,478
+2,422
+20% +$284K 0.01% 469
2025
Q2
$1.62M Buy
12,056
+1,429
+13% +$157K 0.01% 422
2025
Q1
$715K Buy
10,627
+2,478
+30% +$170K 0.01% 649
2024
Q4
$508K Buy
8,149
+2,689
+49% +$250K 0.01% 617
2024
Q3
$857K Buy
5,460
+3,352
+159% +$516K 0.01% 434
2024
Q2
$318K Buy
+2,108
New +$253K ﹤0.01% 696

Other funds holding TMDX

HB Wealth Management's TMDX Position: Q1 2026 in Review

HB Wealth Management increased its Transmedics (TMDX) stake by 0.73% in Q1 2026, buying an estimated $14K and bringing the position to 14,843 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #520.

HB Wealth Management first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.79M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • HB Wealth Management held 14,843 shares of Transmedics worth $1.48M as of Q1 2026.
  • HB Wealth Management bought 107 Transmedics shares in Q1 2026, an estimated $14K.
  • Transmedics made up 0.01% of HB Wealth Management's portfolio in Q1 2026, its #520 holding.
  • HB Wealth Management first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
  • HB Wealth Management's Transmedics position peaked at $1.79M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on HB Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.